Nurse Practitioner, Family · Corbin, KY
NPI
1942642509
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
110 Roy Kidd Ave
Corbin, KY, 40701
Phone (606) 528-7400
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
11,416 prescriptions
Company payments, 2025
$176
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kari R Honeycutt prescribed most often to Medicare patients was Eliquis (Apixaban), with 481 prescriptions and refills. In total Kari R Honeycutt wrote 11,416 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Eliquis Apixaban | 481 | 489 | 55 | $155K |
| Levothyroxine Sodium Generic | 407 | 465 | 86 | $5,800 |
| Sertraline Hcl Generic | 314 | 321 | 33 | $2,998 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 286 | 286 | 65 | $9,438 |
| Atorvastatin Calcium Generic | 263 | 315 | 54 | $4,576 |
| Jardiance Empagliflozin | 251 | 254 | 33 | $83K |
| Pantoprazole Sodium Generic | 239 | 264 | 49 | $12K |
| Linzess Linaclotide | 236 | 240 | 47 | $135K |
| Rexulti Brexpiprazole | 232 | 238 | 28 | $186K |
| Rosuvastatin Calcium Generic | 231 | 288 | 58 | $6,015 |
| Furosemide Generic | 222 | 228 | 61 | $1,231 |
| Lisinopril Generic | 204 | 243 | 44 | $1,759 |
| Metoprolol Succinate Generic | 180 | 214 | 35 | $3,230 |
| Entresto Sacubitril/Valsartan | 163 | 165 | 15 | $58K |
| Hydralazine Hcl Generic | 139 | 147 | 25 | $3,941 |
Brand drugs: 2,984 claims; generic drugs: 8,277 claims; opioid claims: 363.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kari R Honeycutt $176 ($176 in general payments such as food, travel and fees) from 6 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $87.49.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.